BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24792998)

  • 1. Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells.
    Zhang X; Chen H; Wang X; Zhao W; Chen JJ
    Gynecol Oncol; 2014 Aug; 134(2):372-8. PubMed ID: 24792998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of
    Wang Q; Zheng W
    Biomed Res Int; 2021; 2021():6663367. PubMed ID: 33763482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
    Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
    Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells.
    McCabe MT; Powell DR; Zhou W; Vertino PM
    Cancer Genet Cytogenet; 2010 Mar; 197(2):130-41. PubMed ID: 20193846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
    Xiao X; He Q; Lu C; Werle KD; Zhao RX; Chen J; Davis BC; Cui R; Liang J; Xu ZX
    Gynecol Oncol; 2012 Oct; 127(1):249-55. PubMed ID: 22735790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
    Ciccarese F; Zulato E; Indraccolo S
    Oxid Med Cell Longev; 2019; 2019():8730816. PubMed ID: 31781355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and gene expression profiling of LKB1 stable knockdown lung cancer cell line.
    Sun LL; Zhong DS; Wu S; Bai H; Chen Z
    Chin Med J (Engl); 2011 Jul; 124(13):2028-32. PubMed ID: 22088465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K; Singh G
    BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic LKB1 mutations promote cervical cancer progression.
    Wingo SN; Gallardo TD; Akbay EA; Liang MC; Contreras CM; Boren T; Shimamura T; Miller DS; Sharpless NE; Bardeesy N; Kwiatkowski DJ; Schorge JO; Wong KK; Castrillon DH
    PLoS One; 2009; 4(4):e5137. PubMed ID: 19340305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway.
    Jimenez AI; Fernandez P; Dominguez O; Dopazo A; Sanchez-Cespedes M
    Cancer Res; 2003 Mar; 63(6):1382-8. PubMed ID: 12649203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive transcriptome analysis identifies pathways with therapeutic potential in locally advanced cervical cancer.
    Campos-Parra AD; Padua-Bracho A; Pedroza-Torres A; Figueroa-González G; Fernández-Retana J; Millan-Catalan O; Peralta-Zaragoza O; Cantú de León D; Herrera LA; Pérez-Plasencia C
    Gynecol Oncol; 2016 Nov; 143(2):406-413. PubMed ID: 27581326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
    Yang R; Li SW; Chen Z; Zhou X; Ni W; Fu DA; Lu J; Kaye FJ; Wu L
    J Natl Cancer Inst; 2019 Jul; 111(7):664-674. PubMed ID: 30423141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.
    Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
    Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
    Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development.
    Luo Y; Wu Y; Peng Y; Liu X; Bie J; Li S
    Ir J Med Sci; 2016 Feb; 185(1):231-9. PubMed ID: 25786624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
    Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W
    J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.